Volume 8, Issue 2 (May 2021)                   IJML 2021, 8(2): 131-137 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kamali M, Shariati M, Taheri Sarvtin M. Vitamin D Status in Jiroft City Population, South of Iran, 2015-2019. IJML. 2021; 8 (2) :131-137
URL: http://ijml.ssu.ac.ir/article-1-399-en.html
Department of Medical Mycology and Parasitology, Faculty of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran
Full-Text [PDF 283 kb]   (126 Downloads)     |   Abstract (HTML)  (113 Views)
Full-Text:   (19 Views)
Introduction
Vitamin D is a fat-soluble vitamin and steroid hormone that is present in two distinct forms; approximately 10 percent ergocalciferol or vitamin D2, that is in mushrooms, eggs, fortified milk, cod liver oil, fish, and certain plants, while 90 percent comes from cholecalciferol or vitamin D3 that synthesized in the skin from endogenous 7-Dehydrocholesterol during exposure to ultraviolet light [1]. In the circulation, the vitamin hydroxylated first to 25-(OH) D by the liver and then hydroxylated to 1, 25-(OH) D by the kidney that is the active and major circulating form of vitamin D were used to measure vitamin D status [2]. There is a growing awareness that vitamin D sufficiency is needed for optimal health. This vitamin has a vital role in maintaining bone and muscle health via balance in the absorption of calcium and phosphate [3]. Vitamin D plays a vital role in the proliferation and differentiation of various cells [4]. For example, in epithelial cells, vitamin D contributes to maintaining the quiescent, differentiated phenotype and promotes pathways that defend cells against endogenous and exogenous stresses via binding with the vitamin D receptor [5].
Furthermore, during the past two decades, many studies have illustrated the importance of vitamin D in reducing the risk of cancer and some diseases, including multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, diabetes mellitus, autism, psoriasis, infertility, infection, coronary artery disease, depression and dementia [6-8]. The half-life of vitamin D is two months as it stores in the adipose tissue, and it is in the circulation for two weeks [9]. Daily, weekly, or monthly vitamin D intake is needed to achieve a vitamin D status sufficient for normal body functions [10]. Recently, vitamin D deficiency is a global health problem, and many people worldwide are exposed to various diseases related to this vitamin deficiency [11]. To reduce health risks associated with vitamin D deficiency, it is necessary to measure vitamin D levels in people. There are numerous studies on 25-(OH) D level [11-18]. Jiroft city is located in the south of Iran, with a warm and humid climate and unique cultures and lifestyles. So far, no comprehensive study has been done on the level of vitamin D in the people of this city. Furthermore, the level of vitamin D can vary based on geographic area and lifestyle. Therefore, this study was performed to examine the level of vitamin D in Jiroft city, Kerman Province, south of Iran.

Materials and Methods
This cross-sectional study was conducted among people who had come to Nabih Akram laboratory in Jiroft city, Kerman Province, south of Iran during 2015-2019. This study did not have any exclusion criteria. Participants were divided into groups of pediatric (≤ 14 years), juveniles (> 14- ≤ 16 years), adolescences (> 16- ≤ 19 years), adults (> 19- ≤ 60 years), and elderly (> 60 years). Blood sampling was performed regardless of the disease type. Serum samples were separated by centrifugation at 3500 rpm for 5 min. The samples were stored at -20 °C until examination. Vitamin D level is traditionally measured through assays of 25-(OH)D that is the major circulating form of vitamin D. Analysis of 25-(OH)D was done by VIDAS 25-OH vitamin D total testing kits (Biomerieux, Marcy I’Etoile, France) on mini VIDAS automated immunoassay system. Status of 25(OH)D was categorized into deficient (< 20 ng/ml), insufficient (20-29 ng/ml), sufficient (30-100 ng/ml), and potential toxicity (> 100 ng/ml) based on manufacturer’s instructions. This study was proved by the Ethical Committee of the Jiroft University of Medical Sciences, Jiroft, Iran.
Statistical analysis
The collected data were statistically analyzed by SPSS version 23 software using descriptive statistics, Pearson correlation coefficient, and a two-independent t-test. In the study, the p-value of less than 0.05 was considered statistically significant.

Results
A total of 5243 individuals (989 males and 4254 females) were included in this study. The lowest number of participants (N=599) was in 2015, and the highest number of participants (N=1771) was in 2017 (Table 1). The mean age of participants was 35.3 years (SD=16.01; range=0-94) and 34.48 years (SD=22.78; range=0-97) in males and females, respectively. The mean level of vitamin D was 26.03 ng/ml (SD=17.69; range=2.26-134.49) and 24.19 ng/ml (SD=18.21; range=0.76-195.89) in men and women, respectively (P=0.003). The lowest vitamin D levels (mean=23.19 ng/ml) were seen in 2016. The highest levels of vitamin D (mean=27.3 ng/ml) were seen in 2019 (p=0.001). The results are presented in Table 2. The Pearson correlation coefficient show a positive significant relationship between age and level of vitamin D (r=0.192, p=0.001). In this study, 12.2%, 2.1%, 4.0%, 73.4%, and 8.3% of participants were in the group of paediatric, juveniles, adolescences, adults, and old age, respectively. The lowest mean vitamin D level (mean=20.33±15.88 ng/ml) was seen in adolescences group (Fig. 1).
The post-doc test showed that the mean level of vitamin D was significantly higher in the old age group than in the other groups (mean=36.2±26.59 ng/ml; P=0.001). The data indicated that, of the total study participants, 2622 (50%) were vitamin D deficient, 1240 (23.65%) had insufficient vitamin D level, 1335 (25.47%) had sufficient vitamin D level, and 46 (0.88%) study participants had a toxic level of vitamin D (Table 3). The highest (37%) and lowest (9.4%) vitamin D deficiency rates were observed in 2017 and 2019, respectively. The highest (34.3%) and lowest (7.6%) rates of vitamin D insufficiency were detected in 2018 and 2015, respectively. The highest (29.7%) and lowest (11.5%) rate of vitamin D sufficiency were seen in 2018 and 2015, respectively.

Discussion
Various studies have shown that vitamin D deficiency is prevalent throughout the world [11-18]. In Iran, physicians have been special focusing on the deficiency of this vitamin and related diseases for the past five years. The main objective of this study was to evaluate vitamin D levels in the last five years in Jiroft city.  The current study results showed that almost 74% of the participants have an inadequate level of vitamin D.
 
 
Table 1. Distribution of collected samples based on gender and year in Jiroft city
     Year Female Male
Number Percent Number Percent
2015 505 11.9 94 9.5
2016 702 16.5 146 14.8
2017 1449 34.1 322 32.6
2018 1100 25.8 299 30.2
2019 498 11.7 128 12.9
Total 4254 100 989 100
 
Table 2. The mean of age and vitamin D level according to year in Jiroft city
Year Age (year) Vitamin D level (ng/ml)
Mean±SD Range Mean±SD Range
2015 35.23±18.79 0-94 24.27±20.83 5.01-126
2016 34.41±16.48 0-93 23.19±18.44 2.79-126
2017 35.85±16.39 0-93 23.45±18.84 1.13-195.89
2018 35.09±17.89 0-90 25.62±15.87 2.03-134.49
2019 34.62±19.5 0-97 27.3±17.17 0.76-108.20
 
Table 3. The mean of age and vitamin D level according to year in Jiroft city
Age group Deficient Insufficient Sufficient Toxic Total
Paediatric 312(48.7) 181(28.2) 142(22.2) 6(0.9) 641(100)
Juveniles 61(56) 19(17.4) 28(25.7) 1(0.9) 109(100)
Adolescences 129(61.7) 47(22.5) 33(15.8) 0(0) 209(100)
Adults 1997(51.9) 890(23.1) 941(24.4) 21(0.5) 3849(100)
Old age 123(28.3) 103(23.7) 191(43.9) 18(4.1) 435(100)
Total 2622(28.3) 1240(23.7) 1335(25.5) 46(0.9) 5243(100)
Data are presented as number (percent)
 
 
In the present study, 50% of participants were vitamin D deficient. This finding is almost in agreement with Song et al. from Gwangju in Korea, with a total prevalence of 59.7% vitamin D deficiency [14]. In disagreement with the results of the study by Ramnemark et al. conducted in Sweden [15] and study by Hovsepian et al. done in Isfahan in Iran with the total prevalence of 20.8% and 70.4% vitamin D deficiency, respectively [16]. These discrepancies in the results of various studies may be due to several factors, including season, latitude, smoking, aging, adiposity, physical activity, diet, measuring the vitamin, technician's skill in measuring the vitamin, and definition of vitamin D deficiency. The independent samples test showed that the mean level of vitamin D in men was significantly higher than in women. The result of the present study was inconsistent with the findings of Farhud et al. [13], Bawaskar et al. [17], and Ramnemark et al. [15] studies. However, it was consistent with the finding of Rabbani et al. [18] and Again et al. [19] studies. The study's outcome may be due to routine use of chador by women, socioeconomic status, and lifestyle. Besides, in this study, the females were a dominant sex group. Vitamin D deficiency in women can affect female reproduction via disruption in calcium homeostasis, cyclic sex steroid hormone fluctuations, and neurotransmitter function [20]. Our study showed a significant positive relationship between age and level of vitamin D. This finding was consistent with the result of Farhud et al.'s [13] study but was inconsistent with the result of Sochorová et al. [11] and Stein et al. [21] studies. The differences in results may be due to a lack of diversity concerning the participants' ages in Sochorová et al. [11] and Stein et al.'s [21] studies. In the present study, the highest vitamin D deficiency was seen in the adolescent group. Acne, dysmenorrhea, and anemia are diseases that are common in adolescence. Some studies have shown that vitamin D deficiency plays an important role in causing or exacerbating these diseases [20-23]. In the present study, vitamin D deficiency was observed in a high percentage of juveniles. In juveniles, deficiency in this vitamin is associated with juvenile idiopathic arthritis, which is a group of chronic inflammatory conditions affecting the joints, causing swelling, stiffness, and pain [24]. Vitamin D deficiency was found in about fifty percent of the adults' group. One of the causes of diseases such as depression, diabetes, infertility, and cancer common in adults may be vitamin D deficiency [25].
The study shows a high prevalence of vitamin D deficiency among the pediatric group. Therefore, many children are at risk for bone disease and disorders of mineral metabolism [2]. Although the lowest percentage of vitamin D deficiency was found in the elderly in the current study, about one-third of them were deficient in this vitamin. In the elderly, vitamin D deficiency can cause many diseases such as myopathy with muscle pain, fatigue, muscular weakness, gait disturbances, osteomalacia with deep bone pain, and prostate, colon, and breast cancer [26]. In this study, the mean of vitamin D in 2019 was significantly higher than in previous years. This result may be due to the increased awareness of the role of vitamin D in the body and some lifestyle changes. However, further studies are required to assess the level of awareness about vitamin D deficiency among the population at risk in this region.
In the current study, 46 (0.88%) people had toxic levels of the vitamin. In Dudenkov et al.'s [27] study, toxic levels of the vitamin were seen in 37 (0.2%) persons. In Lee et al. [28] study, 89 (0.12%) people had toxic levels of the vitamin. There are many symptoms of vitamin D toxicity such as anorexia, constipation, diarrhea, nausea, vomiting, Bone pain, continuous headaches, drowsiness, irregular heartbeat, muscle, and joint pain, kidney stones, frequent urination, excessive thirst, weakness, and nervousness that appear within a few days or weeks. In healthy individuals, toxicity is not common and occurs almost exclusively in people who take long-term, high-dose supplements without monitoring their blood levels [29]. However, toxic levels of vitamin D may be found in diseases such as granulomatous disorders, lymphomas, and idiopathic infantile hypercalcemia [29, 30]. In granulomatous diseases such as tuberculosis, fungal diseases, sarcoidosis, leprosy, infantile subcutaneous fat necrosis, berylliosis, and giant cell polymyositis, toxic levels of vitamin D is related to the abnormal synthesis of 1,25(OH)2D by macrophages. In lymphomas, the etiology of hypervitaminosis D is not fully recognized. In idiopathic infantile hypercalcemia, dysfunction of 24-hydroxylase (CYP24A1), an enzyme responsible for degradation of both 25(OH)D and 1,25(OH)2D, can increase the level of vitamin D [30]. In the present study, we could not determine the effect of seasons and various diseases on vitamin D level, so it is necessary to design studies in this field.

Conclusion
In conclusion, the current shows a high prevalence of vitamin D deficiency among the Jiroft city population, Kerman Province, south of Iran. All age groups were prone to vitamin D deficiency. Poor vitamin D status was more evident in women than men. In this region, special health plans are needed to correct the vitamin level improve the status of vitamin D. Sun exposure, vitamin D fortified foods, and regular physical activities are recommended to increase vitamin D levels.

Conflict of Interest
The authors of this study claimed that there is no conflict of interest.

Acknowledgment
The author would like to thank Dr. Mehralizadeh for his assistance in this study. This research was funded by Nabih Akram laboratory in Jiroft city.
 
References
[1]. Khayyatzadeh SS, Bagherniya M, Abdollahi Z, Ferns GA, Ghayour‐Mobarhan M. What is the best solution to manage vitamin D deficiency? IUBMB Life 2019; 71(9): 1190-191.
[2]. Kolluri H, Deplewski D. Dilemmas in vitamin d management in children and adolescents. Pediatr Ann. 2019; 48(8): 298-303.
[3]. Gil-Díaz MC, Raynor J, O’Brien KO, Schwartz GJ, Weber DR. Systematic review: associations of calcium intake, vitamin D intake, and physical activity with skeletal outcomes in people with Type 1 diabetes mellitus. Acta Diabetol. 2019; 56(10): 1091-102.
[4]. Basit S. Vitamin D in health and disease: a literature review. Br J Biomed Sci. 2013; 70(4): 161-72.
[5]. Barrea L, Savanelli MC, Di Somma C, Napolitano M, Megna M, Colao A, et al. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. Rev Endocr Metab Disord. 2017; 18(2): 195-205.
[6]. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012; 166(5): 765-78.
[7]. Kamali M, Sarvtin MT, Parsanasab H. Prevalence of candida infection in patients with type 2 diabetes mellitus in Sari, North of Iran. J Biomed Pharmacol. 2016; 9(2): 731-34.
[8]. Schmidt RJ, Niu Q, Eyles DW, Hansen RL, Iosif AM. Neonatal vitamin D status concerning autism spectrum disorder and developmental delay in the CHARGE case-control study. Autism Res. 2019; 12(6): 976-88.
[9]. Liu Q, Zheng X, Liu Z, Qiu L. Vitamin D status is associated with 1, 5-anhydro-D-glucitol status in type 2 diabetes mellitus patients. Appl Physiol Nutr Metab. 2019; 44(8): 857-60.
[10]. Imga NN, Berker D, Can B, Guler S. The effects of three regimens of cholecalciferol (Vitamin D3; supplementation on vitamin D deficiency in non-obese and obese females. Arch Med Sci Atheroscler Dis. 2018; 3(1): 60-67.
[11]. Sochorová L, Hanzlíková L, Černá M, Vosátková M, Grafnetterová AP, Fialová A, et al. Assessment of vitamin D status in Czech children. Cent Eur J Public Health 2018; 26(4): 260-64.
[12]. Alamoudi LH, Almuteeri RZ, Al-Otaibi ME, Alshaer DA, Fatani SK, Alghamdi MM, et al. Awareness of vitamin D deficiency among the general population in Jeddah, Saudi Arabia. J Nutr Metab 2019; 3(3): 1-7.
[13]. Farhud DD, Mehrabi A, Sarafnejad A, Sadeghipour HR, Rahimiforoushani A, Rokni MB, et al. A Comprehensive, epidemiological and ecological descriptive study on vitamin D status in Iran (308005 People, from 2009-2018). Iran J Public Health 2019; 48(4): 644-54.
[14]. Song HR, Kweon SS, Choi JS, Rhee J, Lee YH, Nam HS, et al. High prevalence of vitamin D deficiency in adults aged 50 years and older in Gwangju, Korea: the Dong-gu Study. J Korean Med Sci. 2014; 29(1): 149-52.
[15]. Ramnemark A, Norberg M, Pettersson-Kymmer U, Eliasson M. Adequate vitamin D levels in a Swedish population living above latitude 63 N: the 2009 Northern Sweden MONICA study. Int J Circumpolar Health 2015; 74(1): 27963.
[16]. Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr. 2011; 29(2): 149-155
[17]. Bawaskar PH, Bawaskar HS, Bawaskar PH, Pakhare AP. Profile of vitamin D in patients attending at general hospital Mahad India. Indian J Endocrinol Metab. 2017; 21(1): 125-30.
[18]. Rabbani A, Alavian SM, Motlagh ME, Ashtiani MT, Ardalan G, Salavati A, et al. Vitamin D insufficiency among children and adolescents living in Tehran, Iran. J Trop Pediatr. 2008; 55(3): 189-91.
[19]. Again K, Moghadam SAB. Prevalence of vitamin D deficiency and insufficiency among healthcare professionals in hospital setting at altitude of over 1300 m: Tehran-Iran; Logman Hakim Hospital. J Hosp Med Manag. 2016; 2(1): 1-9.
[20]. Bahrami A, Avan A, Sadeghnia HR, Esmaeili H, Tayefi M, Ghasemi F, et al. High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. Gynecol Endocrinol. 2018; 34(8): 659-63.
[21]. Stein EM, Laing EM, Hall DB, Hausman DB, Kimlin MG, Johnson MA, et al. Serum 25-hydroxyvitamin D concentrations in girls aged 4-8 y living in the southeastern United States. Am J Clin Nutr. 2006; 83(1): 75-81.
[22]. Smith EM, Tangpricha V. Vitamin D and anemia: insights into an emerging association. Curr Opin Endocrinol Diabetes Obes. 2015; 22(6): 432-38.
[23]. Lim SK, Ha JM, Lee YH, Lee Y, Seo YJ, Kim CD, et al. Comparison of vitamin D levels in patients with and without acne: a case-control study combined with a randomized controlled trial. PLoS One 2016; 11(8): 161-69.
[24]. Finch SL, Rosenberg AM, Vatanparast H. Vitamin D and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2018; 16(1): 34-41.
[25] Choi EY. 25(OH)D status and demographic and lifestyle determinants of 25(OH)D among Korean adults. Asia Pac J Clin Nutr. 2012; 21(4): 526-35.
[26]. Eriksen EF, Glerup H. Vitamin D deficiency and aging: implications for general health and osteoporosis. Biogerontology 2002; 3(1-2): 73-7.
[27]. Dudenkov DV, Yawn BP, Oberhelman SS, Fischer PR, Singh RJ, Cha SS, et al. Changing incidence of serum 25-hydroxyvitamin D values above 50 ng/mL: a 10-year population-based study. Mayo Clin Proc. 2015; 90(5): 577-86.
[28]. Lee JP, Tansey M, Jetton JG, Krasowski MD. Vitamin D toxicity: a 16-year retrospective study at an academic medical center. Lab Med. 2018; 49(2): 123-29.
[29]. Alshahrani F, Aljohani N. Vitamin D: deficiency, sufficiency and toxicity. Nutrients 2013; 5(9): 3605-616.
[30]. Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D toxicity-a clinical perspective. Front Endocrinol (Lausanne) 2018; 9: 550.
Type of Study: Research | Subject: Biochemistry
Received: 2021/01/11 | Accepted: 2021/02/21 | Published: 2021/05/31

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 CC BY-NC 4.0 | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb